BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32705535)

  • 1. Hydroxysafflor Yellow A of Carthamus Tinctorius L., Represses the Malignant Development of Esophageal Cancer Cells via Regulating NF-κB Signaling Pathway.
    Chen X; Wang Y; Zhang L; Gao Y
    Cell Biochem Biophys; 2020 Dec; 78(4):511-520. PubMed ID: 32705535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxysafflor yellow A attenuate lipopolysaccharide-induced endothelium inflammatory injury.
    Jin M; Sun CY; Zang BX
    Chin J Integr Med; 2016 Jan; 22(1):36-41. PubMed ID: 26015073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice.
    Yang F; Li J; Zhu J; Wang D; Chen S; Bai X
    Eur J Pharmacol; 2015 May; 754():105-14. PubMed ID: 25720342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective effect of hydroxysafflor yellow A on endothelial cell injury induced by lipopolysaccharide].
    Wang X; Zang B; Wu W; Tong J; Jin M
    Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(12):1650-3. PubMed ID: 22007554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxysafflor yellow A inhibits the proliferation, migration, and invasion of colorectal cancer cells through the PPARγ/PTEN/Akt signaling pathway.
    Su D; Lv C
    Bioengineered; 2021 Dec; 12(2):11533-11543. PubMed ID: 34889713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitory effect of hydroxysafflor yellow A against PMN activation induced by LPS].
    Wu W; Jin M; Tong J; Wang XF; Zang BX
    Yao Xue Xue Bao; 2011 Feb; 46(2):153-7. PubMed ID: 21542285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of hydroxysafflor yellow A on PDGF‑BB‑induced proliferation and migration of vascular smooth muscle cells via mediating Akt signaling.
    Song Y; Long L; Zhang N; Liu Y
    Mol Med Rep; 2014 Sep; 10(3):1555-60. PubMed ID: 24939805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory action of hydroxysafflor yellow A on inflammatory signal transduction pathway related factors in rats with cerebral cortex ischemia].
    Chen TT; Du YJ; Liu XL; Zhu HB
    Yao Xue Xue Bao; 2008 Jun; 43(6):570-5. PubMed ID: 18822957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hydroxysafflor yellow A on proliferation and collagen synthesis of rat vascular adventitial fibroblasts induced by angiotensin II.
    Yuan W; Yang D; Sun X; Liu W; Wang L; Li X; Man X; Fu Q
    Int J Clin Exp Pathol; 2014; 7(9):5772-81. PubMed ID: 25337218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYC/NBS1-Mediated DNA Damage Response is Involved in the Inhibitory Effect of Hydroxysafflor Yellow A on Glioma Cells.
    Tang D; Huang T; Tian Q; Wang J
    Drug Des Devel Ther; 2021; 15():1749-1763. PubMed ID: 33953544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research progress on mechanism of Carthamus tinctorius in ischemic stroke therapy].
    Chen JR; Xie XF; Cao XY; Li GM; Yin YP; Peng C
    Zhongguo Zhong Yao Za Zhi; 2022 Sep; 47(17):4574-4582. PubMed ID: 36164862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxysafflor Yellow A Attenuates Lipopolysaccharide-Induced Neurotoxicity and Neuroinflammation in Primary Mesencephalic Cultures.
    Wang T; Ding YX; He J; Ma CJ; Zhao Y; Wang ZH; Han B
    Molecules; 2018 May; 23(5):. PubMed ID: 29783643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Actions, Molecular Mechanisms, Pharmacokinetic Progressions, and Clinical Applications of Hydroxysafflor Yellow A in Antidiabetic Research.
    Zhang X; Shen D; Feng Y; Li Y; Liao H
    J Immunol Res; 2021; 2021():4560012. PubMed ID: 34938814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxysafflor yellow A ameliorates lipopolysaccharide-induced acute lung injury in mice via modulating toll-like receptor 4 signaling pathways.
    Liu YL; Liu YJ; Liu Y; Li XS; Liu SH; Pan YG; Zhang J; Liu Q; Hao YY
    Int Immunopharmacol; 2014 Dec; 23(2):649-57. PubMed ID: 25466274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats.
    Jin M; Wang L; Wu Y; Zang BX; Tan L
    Chin J Integr Med; 2018 Jan; 24(1):32-39. PubMed ID: 29294256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxysafflor yellow A promotes apoptosis via blocking autophagic flux in liver cancer.
    Wu N; Li J; Luo H; Wang D; Bai X
    Biomed Pharmacother; 2021 Apr; 136():111227. PubMed ID: 33485070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxysafflor Yellow A Inhibits Aβ
    Ren M; Zhang M; Zhang X; Wang C; Zheng Y; Hu Y
    Neurochem Res; 2022 Mar; 47(3):748-761. PubMed ID: 34783973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of PPARγ is required for hydroxysafflor yellow A of Carthamus tinctorius to attenuate hepatic fibrosis induced by oxidative stress.
    Wang CY; Liu Q; Huang QX; Liu JT; He YH; Lu JJ; Bai XY
    Phytomedicine; 2013 May; 20(7):592-9. PubMed ID: 23523101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxysafflor yellow A, a natural compound from Carthamus tinctorius L with good effect of alleviating atherosclerosis.
    Xue X; Deng Y; Wang J; Zhou M; Liao L; Wang C; Peng C; Li Y
    Phytomedicine; 2021 Oct; 91():153694. PubMed ID: 34403879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxysafflor yellow A attenuates left ventricular remodeling after pressure overload-induced cardiac hypertrophy in rats.
    Wang J; Zhang Q; Mei X; Zhang X
    Pharm Biol; 2014 Jan; 52(1):31-5. PubMed ID: 24033225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.